The Effects of Spacer Length and Composition on Aptamer‐Mediated Cell‐Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin
- 28 April 2016
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 17 (12) , 1111-1117
Abstract
Aptamer‐based targeted drug delivery systems have shown significant promise for clinical applications. Although much progress has been made in this area, it remains unclear how PEG coating would affect the selective binding of DNA aptamers and thus influence the overall targeting efficiency. To answer this question, we herein report a systematic investigation of the interactions between PEG and DNA aptamers on the surface of liposomes by using a series of nanoscale liposomal doxorubicin formulations with different DNA aptamer and PEG modifications. We investigated how the spatial size and composition of the spacer molecules affected the targeting ability of the liposome delivery system. We showed that a spacer of appropriate length was critical to overcome the shielding from surrounding PEG molecules in order to achieve the best targeting effect, regardless of the spacer composition. Our findings provide important guidelines for the design of aptamer‐based targeted drug delivery systems.Keywords
This publication has 59 references indexed in Scilit:
- Aptamer-Functionalized Nanoparticles for Medical Applications: Challenges and OpportunitiesACS Nano, 2012
- Scavenger Receptors Mediate Cellular Uptake of Polyvalent Oligonucleotide-Functionalized Gold NanoparticlesBioconjugate Chemistry, 2010
- Functional Nucleic Acid SensorsChemical Reviews, 2009
- Size‐Dependent Endocytosis of NanoparticlesAdvanced Materials, 2009
- Effect of Linker Structure on Surface Density of Aptamer Monolayers and Their Corresponding Protein Binding EfficiencyAnalytical Chemistry, 2008
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences, 2008
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences, 2007
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences, 2007
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006